Global Emerging Infectious Disease Market Research Report 2026(Status and Outlook)

May 2026 | 153 pages | ID: G7F4F9853528EN
Bosson Research

Abstracts

Emerging infectious diseases can be defined as infectious diseases that have newly appeared in a population or have existed but are rapidly increasing in incidence or geographic range, or that are caused by one of the NIAID Category A, B, or C priority pathogens.The global emerging infectious disease market refers to the market for diagnostics, treatments, and preventive measures for newly discovered or re-emerging infectious diseases. Emerging infectious diseases are those that have recently appeared in a population or have existed but are rapidly increasing in incidence or geographic range. These diseases pose a significant public health threat and require innovative approaches for detection, management, and control.Here are some key factors influencing the growth of the global emerging infectious disease market:Outbreaks and epidemics: The occurrence of outbreaks and epidemics of emerging infectious diseases, such as Ebola, Zika virus, and COVID-19, has created a heightened global awareness of the need for robust diagnostic tools, therapeutics, and preventive measures. These outbreaks drive the demand for rapid and accurate diagnostics to identify the causative agents, along with effective treatments and preventive strategies to control the spread of the diseases.Technological advancements: Advances in diagnostic technologies, including nucleic acid amplification techniques, immunoassays, and point-of-care diagnostics, have significantly improved the speed and accuracy of diagnosing emerging infectious diseases. Additionally, the development of new antiviral drugs, vaccines, and other therapeutics has expanded treatment options for these diseases. The integration of technologies such as artificial intelligence, genomics, and big data analytics further enhances the capabilities of the healthcare system in managing emerging infectious diseases.Government initiatives and funding: Governments and international organizations have recognized the need to invest in research and development, surveillance systems, and infrastructure to effectively respond to emerging infectious diseases. Increased funding and initiatives aimed at strengthening healthcare systems, surveillance networks, and research collaborations drive innovations in diagnostics, therapeutics, and preventive measures.Global travel and urbanization: Increased global travel and urbanization contribute to the spread and emergence of infectious diseases. The movement of people across borders allows infections to spread rapidly, making it crucial to have effective measures in place for detection, containment, and treatment. This drives the demand for improved diagnostics, therapeutics, and public health strategies targeting emerging infectious diseases.Antimicrobial resistance: The rise of antimicrobial resistance poses a significant challenge in the management of emerging infectious diseases. The limited effectiveness of existing antibiotics and antiviral drugs necessitates the development of new treatment options, including novel antibiotics, combination therapies, and innovative strategies that target the resistance mechanisms of pathogens.The global emerging infectious disease market can be segmented based on disease type, diagnostic methods, treatment modalities, and geography. Disease types may include viral, bacterial, parasitic, and others. Diagnostic methods can include molecular diagnostics, immunoassays, and rapid diagnostic tests. Treatment modalities may include antiviral drugs, antibiotics, vaccines, and supportive care.Geographically, the market can be divided into regions such as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. The prevalence of different emerging infectious diseases, healthcare infrastructure, and government initiatives may vary across these regions.In summary, the global emerging infectious disease market is driven by outbreaks and epidemics, technological advancements, government initiatives, global travel, and antimicrobial resistance. Key players in the market are focused on developing innovative solutions for diagnostics, treatments, and preventive measures. The market is expected to witness significant growth as the need for effective management of emerging infectious diseases continues to rise globally.

The global Emerging Infectious Disease market size was estimated at USD 21660.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 5.90% during the forecast period.

This report offers a comprehensive and in-depth analysis of the global Emerging Infectious Disease market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global Emerging Infectious Disease market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Emerging Infectious Disease market.

Global Emerging Infectious Disease Market: Market Segmentation Analysis

This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.

A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.

Key Company

• BD
• Abbott
• Roche Diagnostics
• Merck & Co., Inc.
• GlaxoSmithKline plc
• BioMerieux
• Danaher
• Orasure
• Qiagen
• Quidel
• Sysmex
• Gen-Probe
• Cepheid
• Hologic

Market Segmentation (by Type)

• AIDS
• Ebola
• SARS
• Avian Flu
• Chikungunya
• Zika
• Others

Market Segmentation (by Application)

• Clinical Laboratories
• Diagnostic Centers
• Others

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Emerging Infectious Disease Market

Overview of the regional outlook of the Emerging Infectious Disease Market:

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Emerging Infectious Disease Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Emerging Infectious Disease, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Emerging Infectious Disease
1.2 Key Market Segments
  1.2.1 Emerging Infectious Disease Segment by Type
  1.2.2 Emerging Infectious Disease Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 EMERGING INFECTIOUS DISEASE MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Emerging Infectious Disease Market Size (M USD) Estimates and Forecasts (2020-2035)
  2.1.2 Global Emerging Infectious Disease Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 EMERGING INFECTIOUS DISEASE MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Emerging Infectious Disease Product Life Cycle
3.3 Global Emerging Infectious Disease Sales by Manufacturers (2020-2025)
3.4 Global Emerging Infectious Disease Revenue Market Share by Manufacturers (2020-2025)
3.5 Emerging Infectious Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Emerging Infectious Disease Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Emerging Infectious Disease Market Competitive Situation and Trends
  3.8.1 Emerging Infectious Disease Market Concentration Rate
  3.8.2 Global 5 and 10 Largest Emerging Infectious Disease Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 EMERGING INFECTIOUS DISEASE INDUSTRY CHAIN ANALYSIS

4.1 Emerging Infectious Disease Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF EMERGING INFECTIOUS DISEASE MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Emerging Infectious Disease Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 U.S. Tariff Policy – April 2025
  5.6.3 Global Trade Frictions and Their Impacts to Emerging Infectious Disease Market
5.7 ESG Ratings of Leading Companies

6 EMERGING INFECTIOUS DISEASE MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Emerging Infectious Disease Sales Market Share by Type (2020-2025)
6.3 Global Emerging Infectious Disease Market Size by Type (2020-2025)
6.4 Global Emerging Infectious Disease Price by Type (2020-2025)

7 EMERGING INFECTIOUS DISEASE MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Emerging Infectious Disease Market Sales by Application (2020-2025)
7.3 Global Emerging Infectious Disease Market Size (M USD) by Application (2020-2025)
7.4 Global Emerging Infectious Disease Sales Growth Rate by Application (2020-2025)

8 EMERGING INFECTIOUS DISEASE MARKET SALES BY REGION

8.1 Global Emerging Infectious Disease Sales by Region
  8.1.1 Global Emerging Infectious Disease Sales by Region
  8.1.2 Global Emerging Infectious Disease Sales Market Share by Region
8.2 Global Emerging Infectious Disease Market Size by Region
  8.2.1 Global Emerging Infectious Disease Market Size by Region
  8.2.2 Global Emerging Infectious Disease Market Size by Region
8.3 North America
  8.3.1 North America Emerging Infectious Disease Sales by Country
  8.3.2 North America Emerging Infectious Disease Market Size by Country
  8.3.3 U.S. Market Overview
  8.3.4 Canada Market Overview
  8.3.5 Mexico Market Overview
8.4 Europe
  8.4.1 Europe Emerging Infectious Disease Sales by Country
  8.4.2 Europe Emerging Infectious Disease Market Size by Country
  8.4.3 Germany Market Overview
  8.4.4 France Market Overview
  8.4.5 U.K. Market Overview
  8.4.6 Italy Market Overview
  8.4.7 Spain Market Overview
8.5 Asia Pacific
  8.5.1 Asia Pacific Emerging Infectious Disease Sales by Region
  8.5.2 Asia Pacific Emerging Infectious Disease Market Size by Region
  8.5.3 China Market Overview
  8.5.4 Japan Market Overview
  8.5.5 South Korea Market Overview
  8.5.6 India Market Overview
  8.5.7 Southeast Asia Market Overview
8.6 South America
  8.6.1 South America Emerging Infectious Disease Sales by Country
  8.6.2 South America Emerging Infectious Disease Market Size by Country
  8.6.3 Brazil Market Overview
  8.6.4 Argentina Market Overview
  8.6.5 Columbia Market Overview
8.7 Middle East and Africa
  8.7.1 Middle East and Africa Emerging Infectious Disease Sales by Region
  8.7.2 Middle East and Africa Emerging Infectious Disease Market Size by Region
  8.7.3 Saudi Arabia Market Overview
  8.7.4 UAE Market Overview
  8.7.5 Egypt Market Overview
  8.7.6 Nigeria Market Overview
  8.7.7 South Africa Market Overview

9 EMERGING INFECTIOUS DISEASE MARKET PRODUCTION BY REGION

9.1 Global Production of Emerging Infectious Disease by Region(2020-2025)
9.2 Global Emerging Infectious Disease Revenue Market Share by Region (2020-2025)
9.3 Global Emerging Infectious Disease Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Emerging Infectious Disease Production
  9.4.1 North America Emerging Infectious Disease Production Growth Rate (2020-2025)
  9.4.2 North America Emerging Infectious Disease Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Emerging Infectious Disease Production
  9.5.1 Europe Emerging Infectious Disease Production Growth Rate (2020-2025)
  9.5.2 Europe Emerging Infectious Disease Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Emerging Infectious Disease Production (2020-2025)
  9.6.1 Japan Emerging Infectious Disease Production Growth Rate (2020-2025)
  9.6.2 Japan Emerging Infectious Disease Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Emerging Infectious Disease Production (2020-2025)
  9.7.1 China Emerging Infectious Disease Production Growth Rate (2020-2025)
  9.7.2 China Emerging Infectious Disease Production, Revenue, Price and Gross Margin (2020-2025)

10 KEY COMPANIES PROFILE

10.1 BD
  10.1.1 BD Basic Information
  10.1.2 BD Emerging Infectious Disease Product Overview
  10.1.3 BD Emerging Infectious Disease Product Market Performance
  10.1.4 BD Business Overview
  10.1.5 BD SWOT Analysis
  10.1.6 BD Recent Developments
10.2 Abbott
  10.2.1 Abbott Basic Information
  10.2.2 Abbott Emerging Infectious Disease Product Overview
  10.2.3 Abbott Emerging Infectious Disease Product Market Performance
  10.2.4 Abbott Business Overview
  10.2.5 Abbott SWOT Analysis
  10.2.6 Abbott Recent Developments
10.3 Roche Diagnostics
  10.3.1 Roche Diagnostics Basic Information
  10.3.2 Roche Diagnostics Emerging Infectious Disease Product Overview
  10.3.3 Roche Diagnostics Emerging Infectious Disease Product Market Performance
  10.3.4 Roche Diagnostics Business Overview
  10.3.5 Roche Diagnostics SWOT Analysis
  10.3.6 Roche Diagnostics Recent Developments
10.4 Merck and Co., Inc.
  10.4.1 Merck and Co., Inc. Basic Information
  10.4.2 Merck and Co., Inc. Emerging Infectious Disease Product Overview
  10.4.3 Merck and Co., Inc. Emerging Infectious Disease Product Market Performance
  10.4.4 Merck and Co., Inc. Business Overview
  10.4.5 Merck and Co., Inc. Recent Developments
10.5 GlaxoSmithKline plc
  10.5.1 GlaxoSmithKline plc Basic Information
  10.5.2 GlaxoSmithKline plc Emerging Infectious Disease Product Overview
  10.5.3 GlaxoSmithKline plc Emerging Infectious Disease Product Market Performance
  10.5.4 GlaxoSmithKline plc Business Overview
  10.5.5 GlaxoSmithKline plc Recent Developments
10.6 BioMerieux
  10.6.1 BioMerieux Basic Information
  10.6.2 BioMerieux Emerging Infectious Disease Product Overview
  10.6.3 BioMerieux Emerging Infectious Disease Product Market Performance
  10.6.4 BioMerieux Business Overview
  10.6.5 BioMerieux Recent Developments
10.7 Danaher
  10.7.1 Danaher Basic Information
  10.7.2 Danaher Emerging Infectious Disease Product Overview
  10.7.3 Danaher Emerging Infectious Disease Product Market Performance
  10.7.4 Danaher Business Overview
  10.7.5 Danaher Recent Developments
10.8 Orasure
  10.8.1 Orasure Basic Information
  10.8.2 Orasure Emerging Infectious Disease Product Overview
  10.8.3 Orasure Emerging Infectious Disease Product Market Performance
  10.8.4 Orasure Business Overview
  10.8.5 Orasure Recent Developments
10.9 Qiagen
  10.9.1 Qiagen Basic Information
  10.9.2 Qiagen Emerging Infectious Disease Product Overview
  10.9.3 Qiagen Emerging Infectious Disease Product Market Performance
  10.9.4 Qiagen Business Overview
  10.9.5 Qiagen Recent Developments
10.10 Quidel
  10.10.1 Quidel Basic Information
  10.10.2 Quidel Emerging Infectious Disease Product Overview
  10.10.3 Quidel Emerging Infectious Disease Product Market Performance
  10.10.4 Quidel Business Overview
  10.10.5 Quidel Recent Developments
10.11 Sysmex
  10.11.1 Sysmex Basic Information
  10.11.2 Sysmex Emerging Infectious Disease Product Overview
  10.11.3 Sysmex Emerging Infectious Disease Product Market Performance
  10.11.4 Sysmex Business Overview
  10.11.5 Sysmex Recent Developments
10.12 Gen-Probe
  10.12.1 Gen-Probe Basic Information
  10.12.2 Gen-Probe Emerging Infectious Disease Product Overview
  10.12.3 Gen-Probe Emerging Infectious Disease Product Market Performance
  10.12.4 Gen-Probe Business Overview
  10.12.5 Gen-Probe Recent Developments
10.13 Cepheid
  10.13.1 Cepheid Basic Information
  10.13.2 Cepheid Emerging Infectious Disease Product Overview
  10.13.3 Cepheid Emerging Infectious Disease Product Market Performance
  10.13.4 Cepheid Business Overview
  10.13.5 Cepheid Recent Developments
10.14 Hologic
  10.14.1 Hologic Basic Information
  10.14.2 Hologic Emerging Infectious Disease Product Overview
  10.14.3 Hologic Emerging Infectious Disease Product Market Performance
  10.14.4 Hologic Business Overview
  10.14.5 Hologic Recent Developments

11 EMERGING INFECTIOUS DISEASE MARKET FORECAST BY REGION

11.1 Global Emerging Infectious Disease Market Size Forecast
11.2 Global Emerging Infectious Disease Market Forecast by Region
  11.2.1 North America Market Size Forecast by Country
  11.2.2 Europe Emerging Infectious Disease Market Size Forecast by Country
  11.2.3 Asia Pacific Emerging Infectious Disease Market Size Forecast by Region
  11.2.4 South America Emerging Infectious Disease Market Size Forecast by Country
  11.2.5 Middle East and Africa Forecasted Sales of Emerging Infectious Disease by Country

12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)

12.1 Global Emerging Infectious Disease Market Forecast by Type (2026-2035)
  12.1.1 Global Forecasted Sales of Emerging Infectious Disease by Type (2026-2035)
  12.1.2 Global Emerging Infectious Disease Market Size Forecast by Type (2026-2035)
  12.1.3 Global Forecasted Price of Emerging Infectious Disease by Type (2026-2035)
12.2 Global Emerging Infectious Disease Market Forecast by Application (2026-2035)
  12.2.1 Global Emerging Infectious Disease Sales (K Units) Forecast by Application
  12.2.2 Global Emerging Infectious Disease Market Size (M USD) Forecast by Application (2026-2035)

13 CONCLUSION AND KEY FINDINGS

List Of Tables

LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Emerging Infectious Disease Market Size by Type (M USD)
Table 4. Global Emerging Infectious Disease Market Size by Application
Table 5. Emerging Infectious Disease Market Size Comparison by Region (M USD)
Table 6. Global Emerging Infectious Disease Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Emerging Infectious Disease Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Emerging Infectious Disease Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Emerging Infectious Disease Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Emerging Infectious Disease as of 2025)
Table 11. Global Market Emerging Infectious Disease Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers’ Manufacturing Sites, Areas Served
Table 13. Manufacturers’ Product Type
Table 14. Global Emerging Infectious Disease Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Emerging Infectious Disease Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Emerging Infectious Disease Sales by Type (K Units)
Table 27. Global Emerging Infectious Disease Market Size by Type (M USD)
Table 28. Global Emerging Infectious Disease Sales (K Units) by Type (2020-2025)
Table 29. Global Emerging Infectious Disease Sales Market Share by Type (2020-2025)
Table 30. Global Emerging Infectious Disease Market Size (M USD) by Type (2020-2025)
Table 31. Global Emerging Infectious Disease Market Share by Type (2020-2025)
Table 32. Global Emerging Infectious Disease Price (USD/Unit) by Type (2020-2025)
Table 33. Global Emerging Infectious Disease Sales (K Units) by Application
Table 34. Global Emerging Infectious Disease Market Size by Application
Table 35. Global Emerging Infectious Disease Sales by Application (2020-2025) & (K Units)
Table 36. Global Emerging Infectious Disease Sales Market Share by Application (2020-2025)
Table 37. Global Emerging Infectious Disease Market Size by Application (2020-2025) & (M USD)
Table 38. Global Emerging Infectious Disease Market Share by Application (2020-2025)
Table 39. Global Emerging Infectious Disease Sales Growth Rate by Application (2020-2025)
Table 40. Global Emerging Infectious Disease Sales by Region (2020-2025) & (K Units)
Table 41. Global Emerging Infectious Disease Sales Market Share by Region (2020-2025)
Table 42. Global Emerging Infectious Disease Market Size by Region (2020-2025) & (M USD)
Table 43. Global Emerging Infectious Disease Market Size by Region (2020-2025)
Table 44. North America Emerging Infectious Disease Sales by Country (2020-2025) & (K Units)
Table 45. North America Emerging Infectious Disease Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Emerging Infectious Disease Sales by Country (2020-2025) & (K Units)
Table 47. Europe Emerging Infectious Disease Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Emerging Infectious Disease Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Emerging Infectious Disease Market Size by Region (2020-2025) & (M USD)
Table 50. South America Emerging Infectious Disease Sales by Country (2020-2025) & (K Units)
Table 51. South America Emerging Infectious Disease Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Emerging Infectious Disease Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Emerging Infectious Disease Market Size by Region (2020-2025) & (M USD)
Table 54. Global Emerging Infectious Disease Production (K Units) by Region(2020-2025)
Table 55. Global Emerging Infectious Disease Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Emerging Infectious Disease Revenue Market Share by Region (2020-2025)
Table 57. Global Emerging Infectious Disease Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Emerging Infectious Disease Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Emerging Infectious Disease Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Emerging Infectious Disease Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Emerging Infectious Disease Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. BD Basic Information
Table 63. BD Emerging Infectious Disease Product Overview
Table 64. BD Emerging Infectious Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. BD Business Overview
Table 66. BD SWOT Analysis
Table 67. BD Recent Developments
Table 68. Abbott Basic Information
Table 69. Abbott Emerging Infectious Disease Product Overview
Table 70. Abbott Emerging Infectious Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Abbott Business Overview
Table 72. Abbott SWOT Analysis
Table 73. Abbott Recent Developments
Table 74. Roche Diagnostics Basic Information
Table 75. Roche Diagnostics Emerging Infectious Disease Product Overview
Table 76. Roche Diagnostics Emerging Infectious Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Roche Diagnostics Business Overview
Table 78. Roche Diagnostics SWOT Analysis
Table 79. Roche Diagnostics Recent Developments
Table 80. Merck and Co., Inc. Basic Information
Table 81. Merck and Co., Inc. Emerging Infectious Disease Product Overview
Table 82. Merck and Co., Inc. Emerging Infectious Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Merck and Co., Inc. Business Overview
Table 84. Merck and Co., Inc. Recent Developments
Table 85. GlaxoSmithKline plc Basic Information
Table 86. GlaxoSmithKline plc Emerging Infectious Disease Product Overview
Table 87. GlaxoSmithKline plc Emerging Infectious Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. GlaxoSmithKline plc Business Overview
Table 89. GlaxoSmithKline plc Recent Developments
Table 90. BioMerieux Basic Information
Table 91. BioMerieux Emerging Infectious Disease Product Overview
Table 92. BioMerieux Emerging Infectious Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. BioMerieux Business Overview
Table 94. BioMerieux Recent Developments
Table 95. Danaher Basic Information
Table 96. Danaher Emerging Infectious Disease Product Overview
Table 97. Danaher Emerging Infectious Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Danaher Business Overview
Table 99. Danaher Recent Developments
Table 100. Orasure Basic Information
Table 101. Orasure Emerging Infectious Disease Product Overview
Table 102. Orasure Emerging Infectious Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Orasure Business Overview
Table 104. Orasure Recent Developments
Table 105. Qiagen Basic Information
Table 106. Qiagen Emerging Infectious Disease Product Overview
Table 107. Qiagen Emerging Infectious Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Qiagen Business Overview
Table 109. Qiagen Recent Developments
Table 110. Quidel Basic Information
Table 111. Quidel Emerging Infectious Disease Product Overview
Table 112. Quidel Emerging Infectious Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Quidel Business Overview
Table 114. Quidel Recent Developments
Table 115. Sysmex Basic Information
Table 116. Sysmex Emerging Infectious Disease Product Overview
Table 117. Sysmex Emerging Infectious Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Sysmex Business Overview
Table 119. Sysmex Recent Developments
Table 120. Gen-Probe Basic Information
Table 121. Gen-Probe Emerging Infectious Disease Product Overview
Table 122. Gen-Probe Emerging Infectious Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Gen-Probe Business Overview
Table 124. Gen-Probe Recent Developments
Table 125. Cepheid Basic Information
Table 126. Cepheid Emerging Infectious Disease Product Overview
Table 127. Cepheid Emerging Infectious Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Cepheid Business Overview
Table 129. Cepheid Recent Developments
Table 130. Hologic Basic Information
Table 131. Hologic Emerging Infectious Disease Product Overview
Table 132. Hologic Emerging Infectious Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. Hologic Business Overview
Table 134. Hologic Recent Developments
Table 135. Global Emerging Infectious Disease Sales Forecast by Region (2026-2035) & (K Units)
Table 136. Global Emerging Infectious Disease Market Size Forecast by Region (2026-2035) & (M USD)
Table 137. North America Emerging Infectious Disease Sales Forecast by Country (2026-2035) & (K Units)
Table 138. North America Emerging Infectious Disease Market Size Forecast by Country (2026-2035) & (M USD)
Table 139. Europe Emerging Infectious Disease Sales Forecast by Country (2026-2035) & (K Units)
Table 140. Europe Emerging Infectious Disease Market Size Forecast by Country (2026-2035) & (M USD)
Table 141. Asia Pacific Emerging Infectious Disease Sales Forecast by Region (2026-2035) & (K Units)
Table 142. Asia Pacific Emerging Infectious Disease Market Size Forecast by Region (2026-2035) & (M USD)
Table 143. South America Emerging Infectious Disease Sales Forecast by Country (2026-2035) & (K Units)
Table 144. South America Emerging Infectious Disease Market Size Forecast by Country (2026-2035) & (M USD)
Table 145. Middle East and Africa Emerging Infectious Disease Sales Forecast by Country (2026-2035) & (Units)
Table 146. Middle East and Africa Emerging Infectious Disease Market Size Forecast by Country (2026-2035) & (M USD)
Table 147. Global Emerging Infectious Disease Sales Forecast by Type (2026-2035) & (K Units)
Table 148. Global Emerging Infectious Disease Market Size Forecast by Type (2026-2035) & (M USD)
Table 149. Global Emerging Infectious Disease Price Forecast by Type (2026-2035) & (USD/Unit)
Table 150. Global Emerging Infectious Disease Sales (K Units) Forecast by Application (2026-2035)
Table 151. Global Emerging Infectious Disease Market Size Forecast by Application (2026-2035) & (M USD)

List Of Figures

LIST OF FIGURES

Figure 1. Product Picture of Emerging Infectious Disease
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Emerging Infectious Disease Market Size (M USD), 2025-2035
Figure 5. Global Emerging Infectious Disease Market Size (M USD) (2020-2035)
Figure 6. Global Emerging Infectious Disease Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Emerging Infectious Disease Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Emerging Infectious Disease Product Life Cycle
Figure 13. Emerging Infectious Disease Sales Share by Manufacturers in 2025
Figure 14. Global Emerging Infectious Disease Revenue Share by Manufacturers in 2025
Figure 15. Emerging Infectious Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Emerging Infectious Disease Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Emerging Infectious Disease Revenue in 2025
Figure 18. Industry Chain Map of Emerging Infectious Disease
Figure 19. Global Emerging Infectious Disease Market PEST Analysis
Figure 20. Global Emerging Infectious Disease Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Emerging Infectious Disease Market Share by Type
Figure 27. Sales Market Share of Emerging Infectious Disease by Type (2020-2025)
Figure 28. Sales Market Share of Emerging Infectious Disease by Type in 2025
Figure 29. Market Share of Emerging Infectious Disease by Type (2020-2025)
Figure 30. Market Share of Emerging Infectious Disease by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Emerging Infectious Disease Market Share by Application
Figure 33. Global Emerging Infectious Disease Sales Market Share by Application (2020-2025)
Figure 34. Global Emerging Infectious Disease Sales Market Share by Application in 2025
Figure 35. Global Emerging Infectious Disease Market Share by Application (2020-2025)
Figure 36. Global Emerging Infectious Disease Market Share by Application in 2025
Figure 37. Global Emerging Infectious Disease Sales Growth Rate by Application (2020-2025)
Figure 38. Global Emerging Infectious Disease Sales Market Share by Region (2020-2025)
Figure 39. Global Emerging Infectious Disease Market Size by Region (2020-2025)
Figure 40. North America Emerging Infectious Disease Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Emerging Infectious Disease Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Emerging Infectious Disease Sales Market Share by Country in 2024
Figure 43. North America Emerging Infectious Disease Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Emerging Infectious Disease Market Size by Country in 2024
Figure 45. U.S. Emerging Infectious Disease Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Emerging Infectious Disease Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Emerging Infectious Disease Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Emerging Infectious Disease Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Emerging Infectious Disease Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Emerging Infectious Disease Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Emerging Infectious Disease Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Emerging Infectious Disease Sales Market Share by Country in 2024
Figure 53. Europe Emerging Infectious Disease Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Emerging Infectious Disease Market Size by Country in 2024
Figure 55. Germany Emerging Infectious Disease Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Emerging Infectious Disease Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Emerging Infectious Disease Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Emerging Infectious Disease Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Emerging Infectious Disease Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Emerging Infectious Disease Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Emerging Infectious Disease Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Emerging Infectious Disease Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Emerging Infectious Disease Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Emerging Infectious Disease Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Emerging Infectious Disease Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Emerging Infectious Disease Sales Market Share by Region in 2024
Figure 67. Asia Pacific Emerging Infectious Disease Market Size by Region in 2024
Figure 68. China Emerging Infectious Disease Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Emerging Infectious Disease Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Emerging Infectious Disease Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Emerging Infectious Disease Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Emerging Infectious Disease Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Emerging Infectious Disease Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Emerging Infectious Disease Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Emerging Infectious Disease Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Emerging Infectious Disease Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Emerging Infectious Disease Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Emerging Infectious Disease Sales and Growth Rate (K Units)
Figure 79. South America Emerging Infectious Disease Sales Market Share by Country in 2024
Figure 80. South America Emerging Infectious Disease Market Size and Growth Rate (M USD)
Figure 81. South America Emerging Infectious Disease Market Size by Country in 2024
Figure 82. Brazil Emerging Infectious Disease Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Emerging Infectious Disease Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Emerging Infectious Disease Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Emerging Infectious Disease Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Emerging Infectious Disease Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Emerging Infectious Disease Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Emerging Infectious Disease Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Emerging Infectious Disease Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Emerging Infectious Disease Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Emerging Infectious Disease Market Size by Region in 2024
Figure 92. Saudi Arabia Emerging Infectious Disease Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Emerging Infectious Disease Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Emerging Infectious Disease Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Emerging Infectious Disease Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Emerging Infectious Disease Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Emerging Infectious Disease Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Emerging Infectious Disease Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Emerging Infectious Disease Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Emerging Infectious Disease Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Emerging Infectious Disease Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Emerging Infectious Disease Production Market Share by Region (2020-2025)
Figure 103. North America Emerging Infectious Disease Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Emerging Infectious Disease Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Emerging Infectious Disease Production (K Units) Growth Rate (2020-2025)
Figure 106. China Emerging Infectious Disease Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Emerging Infectious Disease Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Emerging Infectious Disease Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Emerging Infectious Disease Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Emerging Infectious Disease Market Share Forecast by Type (2026-2035)
Figure 111. Global Emerging Infectious Disease Sales Forecast by Application (2026-2035)
Figure 112. Global Emerging Infectious Disease Market Share Forecast by Application (2026-2035)